Results 51 to 60 of about 2,432 (126)
Abstract For six decades, pregnant women have been routinely excluded from pharmaceutical clinical trials, a practice rooted in a protectionist ethic that emerged after the thalidomide tragedy. This narrative review examines whether that exclusion remains ethically justifiable, drawing on the obstetric, pharmacological, and bioethical literature ...
Camila Kruger Cabar +1 more
wiley +1 more source
Abstract Objective To characterize the cord blood metabolic profile of infants born after suspected preterm labor (sPTL) according to whether delivery occurred preterm or at term compared with infants from uncomplicated pregnancies. Study Design Prospective observational cohort study including singleton pregnancies complicated by sPTL and uncomplicated
Lina Youssef +14 more
wiley +1 more source
ABSTRACT Objective To assess the efficacy and safety of transplacental flecainide and/or digoxin for fetal tachyarrhythmias when sotalol is unavailable. Method We evaluated transplacental flecainide, digoxin, or combination therapy in a retrospective and prospective cohort across two Thai tertiary centers.
Mukpradab Darakamas +6 more
wiley +1 more source
ABSTRACT Objective To evaluate the long‐term impact of a structured, multidisciplinary CS reduction strategy in a high‐complexity Italian hospital. Design Retrospective ecological time‐trend study. Setting Tertiary obstetric care Italian centre. Sample 28 577 deliveries, ≥ 22 weeks' gestation, from 2014 to 2024 were analysed.
Stefania Fieni +4 more
wiley +1 more source
Background: One of the main causes of infant morbidity and mortality is preterm birth, which is defined as delivery before 37 weeks of gestation. Tocolytic therapy is essential to delay delivery, allowing corticosteroid administration for fetal lung ...
Nimrah Ehsan +5 more
doaj +1 more source
BackgroundSubcutaneous terbutaline (SQ terbutaline) infusion by pump is used in pregnant women as a prolonged (beyond 48-72 h) maintenance tocolytic following acute treatment of preterm contractions.
Laura M Gaudet +5 more
doaj +1 more source
Prevention of Preterm Labour: 2011 Update on Tocolysis
The aim of this paper is to review available data about drugs for preventing preterm labour. Tocolytic therapy includes β adrenergic receptor agonists, NO donors, magnesium sulphate, prostaglandin-synthase inhibitors, oxytocin receptor antagonists ...
C. Hubinont, F. Debieve
doaj +1 more source
Intrauterine resuscitation includes different interventions which aim to improve fetal oxygenation when intrapartum fetal hypoxic stress leading to abnormal CTG features is suspected.
Stefania Fieni +4 more
doaj +1 more source
This prospective observational study included patients diagnosed with TPL between 24 and 37 weeks of gestation who received tocolytic therapy at a tertiary university hospital between June 2021 and January 2023.
Bilge Çetinkaya Demir, Sevgi Şenol
doaj +1 more source

